NCI H630R1); 5-FU-resistant breast cancer cell lines Antibodies

NCI H630R1); 5-FU-resistant breast cancer cell lines

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK